Beneficial Effect of Dose Escalation of Octreotide-LAR as First-Line Therapy in Patients With Resistant Acromegaly
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Octreotide (Primary)
- Indications Acromegaly
- Focus Therapeutic Use
- Acronyms HDacro
Most Recent Events
- 02 Jun 2015 New trial record